Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine.
Mônica Roberto GadelhaAlessandra CasagrandeChristian J StrasburgerMartin BidlingmaierPeter J SnyderMirtha A GuitelmanCesar L BoguszewskiMichael BuchfelderIlan ShimonGerald RaverotMiklós TóthEmese MezősiMirjana DoknicXiaolin FanDavid ClemmonsPeter J TrainerR Scott StruthersAlan KrasnerBeverly M K BillerPublished in: The Journal of clinical endocrinology and metabolism (2024)
Replacement of injected SRLs by once-daily oral paltusotine was effective in maintaining both biochemical and symptom control in patients with acromegaly and was well tolerated.
Keyphrases